The College of the Florida Keys will open its 2025 VIP Series with back-to-back presentations on Wednesday, Jan. 15, at 7 p.m ...

Meet with Scarborough's local team of independent travel experts and hear about the go to locations for 2025 holidays. Pebble Shore Travel work with cruise lines including Cunard, Celebrity Cruises ...

The Galapagos is an outdoor destination—visitors are typically on boats, in the water, or hiking—so good weather is important ...

Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

Asheville, North Carolina has been placed in the top 20 on a list of 52 travel destinations for 2025 by the New York Times.

Galapagos NV is abandoning its small molecule roots to focus on cell therapy and at the same time splitting in two, with the spinout company, dedicated to acquiring a portfolio of assets, taking the ...

During his famed voyage on the HMS Beagle, Charles Darwin noted about the Galápagos Islands that “by far the most remarkable ...

By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...

Leerink Partners analyst Faisal Khurshid has maintained their neutral stance on GLPG stock, giving a Hold rating on December 23.Stay Ahead of ...

Alongside plans to spin out a new company, the Belgian drugmaker said it will cut some 300 positions, or about 40% of its ...

Bank of America Securities analyst Jason Gerberry maintained a Sell rating on Galapagos (GLPG – Research Report) today and set a price target ...

The changes will result in one company focused exclusively on cancer cell therapies and another on strategic transactions to build a pipeline of innovative medicines.